These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32457832)

  • 1. Managing Metastatic Thymoma With Metabolic and Medical Therapy: A Case Report.
    Phillips MCL; Murtagh DKJ; Sinha SK; Moon BG
    Front Oncol; 2020; 10():578. PubMed ID: 32457832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoma. Histologic subclassification is an independent prognostic factor.
    Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
    Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoma: results of 241 operated cases.
    Maggi G; Casadio C; Cavallo A; Cianci R; Molinatti M; Ruffini E
    Ann Thorac Surg; 1991 Jan; 51(1):152-6. PubMed ID: 1985561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
    Zhang Y; Yu L; Jing Y; Ke J
    Zhonghua Wai Ke Za Zhi; 2015 Aug; 53(8):612-6. PubMed ID: 26653963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant thymomas--the experience of the Portuguese Oncological Institute, Porto, and literature review.
    Sousa B; Araújo A; Amaro T; Azevedo I; Soares M; Sousa O
    Rev Port Pneumol; 2007; 13(4):553-85. PubMed ID: 17898913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymic tumours associated with Myasthenia gravis: a long term observation study of operated patients.
    Bak V; Spalek P; Petrovajova T; Vichova B; Oravsky M; Luha J; Schnorrer M
    Bratisl Lek Listy; 2013; 114(8):464-8. PubMed ID: 23944622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoma: prognostic factors and treatment outcomes.
    Gripp S; Hilgers K; Wurm R; Schmitt G
    Cancer; 1998 Oct; 83(8):1495-503. PubMed ID: 9781943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of CD20 in thymomas and its clinical implication].
    Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a Ketogenic Diet on Sporadic Inclusion Body Myositis: A Case Study.
    Phillips MCL; Murtagh DKJ; Ziad F; Johnston SE; Moon BG
    Front Neurol; 2020; 11():582402. PubMed ID: 33224095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current therapy for thymoma.
    Cooper JD
    Chest; 1993 Apr; 103(4 Suppl):334S-336S. PubMed ID: 8462324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results after treatment for recurrent thymoma: a multicenter analysis.
    Sandri A; Cusumano G; Lococo F; Alifano M; Granone P; Margaritora S; Cesario A; Oliaro A; Filosso P; Regnard JF; Ruffini E
    J Thorac Oncol; 2014 Dec; 9(12):1796-804. PubMed ID: 25393792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
    Kuo TT; Chan JK
    Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.
    Mornex F; Resbeut M; Richaud P; Jung GM; Mirabel X; Marchal C; Lagrange JL; Rambert P; Chaplain G; Nguyen TD
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):651-9. PubMed ID: 7790251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological aspects of microscopic thymoma with myasthenia gravis and review of published reports.
    Fukuhara M; Higuchi M; Owada Y; Inoue T; Watanabe Y; Yamaura T; Muto S; Hasegawa T; Suzuki H
    J Thorac Dis; 2017 Jun; 9(6):1592-1597. PubMed ID: 28740673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary treated thymomas with fatal outcome. A retrospective study.
    Ionescu L; Dănilă R; Timofte D; Butcovan D; Stefanescu C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):675-8. PubMed ID: 25341283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK; Marx A
    Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series.
    Phillips MCL; Leyden J; McManus EJ; Lowyim DG; Ziad F; Moon BG; Haji Mohd Yasin NAB; Tan A; Thotathil Z; Jameson MB
    J Oncol; 2022; 2022():4496734. PubMed ID: 36276276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thymic tumors].
    Le Péchoux C; Mahé M; Bretel JJ; Roberti E; Ruffié P
    Cancer Radiother; 2005 Nov; 9(6-7):351-7. PubMed ID: 16168694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thymoma with immunodeficiency/Good syndrome associated with myasthenia gravis].
    Takai S; Tagawa A; Ogawa T; Kato H; Saito N; Okada S
    Rinsho Shinkeigaku; 2017 May; 57(5):208-213. PubMed ID: 28450687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.